125 related articles for article (PubMed ID: 1698422)
1. Successful treatment for perinephric abscess with recombinant human granulocyte colony-stimulating factor following nephrectomy in a patient of myelodysplastic syndrome: a case report.
Tamura K; Takeuchi M; Hirakawa N; Toyoda K; Minoda M
Biotherapy; 1990; 2(3):223-6. PubMed ID: 1698422
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
Yoshida Y; Asano S; Hirashima K; Takaku F
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():349-52. PubMed ID: 1284304
[No Abstract] [Full Text] [Related]
3. Investigation of coronary artery bypass grafting for a patient with myelodysplastic syndrome.
Miyagi Y; Yamauchi S; Suzuki S; Kitagawa A; Masaki Y; Gomibuchi M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):250-3. PubMed ID: 11578269
[TBL] [Abstract][Full Text] [Related]
4. [Hematological effect of 14 days treatment of recombinant human granulocyte colony-stimulating factor for neutropenia in myelodysplastic syndromes].
Yoshida Y; Hirashima K; Asano S; Takaku F; Furusawa S; Ogawa T; Arimori S; Abe T; Suzuki T; Kato Y
Rinsho Ketsueki; 1991 Jul; 32(7):743-50. PubMed ID: 1717726
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia.
Sultana TA; Harada H; Ito K; Tanaka H; Kyo T; Kimura A
Br J Haematol; 2003 Apr; 121(1):63-75. PubMed ID: 12670333
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive mitral valve repair via right mini-thoracotomy in patient with myelodysplastic syndrome.
Taguchi T; Nishi H; Kurose K; Horikawa K; Kanazawa G; Takahashi T
J Cardiothorac Surg; 2018 May; 13(1):45. PubMed ID: 29776423
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes.
Yoshida Y; Hirashima K; Asano S; Takaku F
Br J Haematol; 1991 Jul; 78(3):378-84. PubMed ID: 1714759
[TBL] [Abstract][Full Text] [Related]
8. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report.
Kobayashi Y; Okabe T; Ozawa K; Chiba S; Hino M; Miyazono K; Urabe A; Takaku F
Am J Med; 1989 Feb; 86(2):178-82. PubMed ID: 2464280
[TBL] [Abstract][Full Text] [Related]
9. Absence of mutations in the granulocyte colony-stimulating factor (G-CSF) receptor gene in patients with myelodysplastic syndrome/acute myeloblastic leukaemia occurring after treatment of aplastic anaemia with G-CSF.
Kudo K; Nagai H; Numata S; Ichihara M; Kinoshita T; Horibe K; Kato K; Matsuyama T; Kodera Y; Kojima S
Br J Haematol; 2000 Nov; 111(2):656-8. PubMed ID: 11122117
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.
Miller K
Leuk Res; 1998 May; 22 Suppl 1():S13-6. PubMed ID: 9734694
[No Abstract] [Full Text] [Related]
12. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
[TBL] [Abstract][Full Text] [Related]
14. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
15. Revisiting use of growth factors in myelodysplastic syndromes.
Newman K; Maness-Harris L; El-Hemaidi I; Akhtari M
Asian Pac J Cancer Prev; 2012; 13(4):1081-91. PubMed ID: 22799286
[TBL] [Abstract][Full Text] [Related]
16. [Lung abscess secondary to neutropenic myelodysplasia treated with G-CSF].
Guilleminault L; Espanel C; Marcq M; Azzouz M; Diot E; Binet C; Diot P
Rev Mal Respir; 2009 Jan; 26(1):87-9. PubMed ID: 19212297
[No Abstract] [Full Text] [Related]
17. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
[TBL] [Abstract][Full Text] [Related]
18. Successful non-surgical treatment of brain abscess and necrotizing fasciitis caused by Bacillus cereus.
Mori T; Tokuhira M; Takae Y; Mori S; Suzuki H; Abe T; Takeuchi T
Intern Med; 2002 Aug; 41(8):671-3. PubMed ID: 12211541
[TBL] [Abstract][Full Text] [Related]
19. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
20. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
